Skip to content
Home/Companies/Biotech/BRAIN Biotech
BRAIN Biotech

BRAIN Biotech

Biotech·Germany·Exited 2016·Held 10yr
Entry
2006
Hold
10yr
Exit
2016

Who owns BRAIN Biotech?

BRAIN Biotech was owned by MIG Capital through MIG Fonds 5 (2007 vintage) from 2006 to 2016, exited via IPO.

Hand-verified · updated 2026-07-03

MIG Capital
Investor
MIG Capital
MIG Fonds 5 · 2007 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusAcquired
Websitewww.biotechgate.com
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2016

More from MIG Fonds 5

Other portfolio companies in the same fund.

advanceCOR
Active
BiotechGermany· 2012
Immatics
Immatics
Exited 2020
BiotechGermany· 2010
AmSilk
Active
BiotechGermany· 2008
instrAction
instrAction
Active
Deep TechGermany· 2008
OD-OS
Od-os
Active
MedTechGermany· 2008
Ganymed Pharmaceuticals
Exited 2016
BiotechGermany· 2007
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track BRAIN Biotech

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy BRAIN Biotech?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on BRAIN Biotech.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue